Company / Profit Margin
GT Biopharma, Inc. Profit Margin History
FY2011-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-121207.4%
FY2016
5-year range
-121207.4% / -136.1%
FY2012-FY2016
Trend
-214.8%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin changed -215% YoY in FY2016, a notable deviation from the 5-year average annual change of -5634%.
Based on SEC 10-K filings.
-121207.4% in FY2016 with a 5-year CAGR of -93980.1%.
Declined from -136.1% to -121207.4% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -119695.4pp
- 5-Year Change
- -93980.1pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2016, profit margin decreased 214.8% year-over-year.
- Peak profit margin was recorded in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | - | - |
| FY2017 | - | - |
| FY2016 | -121207.4% | -214.8% |
| FY2015 | -38506.6% | -28184.5% |
| FY2014 | -136.1% | +91.0% |
| FY2013 | -1512.0% | +89.4% |
| FY2012 | -14230.8% | +47.7% |
| FY2011 | -27227.3% | - |
As of FY2016 · SEC 10-K · Updated Jun 24, 2026